<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation - Kharfan‐Dabaja, M - 2014 | Cochrane Library</title> <meta content="Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation - Kharfan‐Dabaja, M - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010280.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation - Kharfan‐Dabaja, M - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010280.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010280.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation" name="citation_title"/> <meta content="Mohamed Kharfan‐Dabaja" name="citation_author"/> <meta content="Rahul Mhaskar" name="citation_author"/> <meta content="University of South Florida" name="citation_author_institution"/> <meta content="Tea Reljic" name="citation_author"/> <meta content="University of South Florida" name="citation_author_institution"/> <meta content="Joseph Pidala" name="citation_author"/> <meta content="H. Lee Moffitt Cancer Center, Division of Oncologic Sciences, University of South Florida" name="citation_author_institution"/> <meta content="Janelle B Perkins" name="citation_author"/> <meta content="Division of Oncologic Sciences, University of South Florida" name="citation_author_institution"/> <meta content="Benjamin Djulbegovic" name="citation_author"/> <meta content="Ambuj Kumar" name="citation_author"/> <meta content="University of South Florida" name="citation_author_institution"/> <meta content="akumar1@health.usf.edu" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD010280.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010280.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010280.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010280.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Allografts; Calcineurin Inhibitors; Cyclosporine [therapeutic use]; Graft vs Host Disease [mortality, *prevention &amp; control]; Hematopoietic Stem Cell Transplantation [*adverse effects]; Immunosuppressive Agents [adverse effects, *therapeutic use]; Methotrexate [adverse effects, *therapeutic use]; Mycophenolic Acid [adverse effects, *analogs &amp; derivatives, therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010280.pub2&amp;doi=10.1002/14651858.CD010280.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010280\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010280\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010280.pub2",title:"Mycophenolate mofetil versus methotrexate for prevention of graft\\u2010versus\\u2010host disease in people receiving allogeneic hematopoietic stem cell transplantation",firstPublishedDate:"Jul 25, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Haematological Malignancies Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010280.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010280.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010280.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010280.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010280.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010280.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010280.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010280.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010280.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010280.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2206 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010280.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/appendices#CD010280-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/table_n/CD010280StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/table_n/CD010280StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0002">Mohamed Kharfan‐Dabaja</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0003">Rahul Mhaskar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0004">Tea Reljic</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0005">Joseph Pidala</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0006">Janelle B Perkins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0007">Benjamin Djulbegovic</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information#CD010280-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Ambuj Kumar</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information/en#CD010280-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010280.pub2">https://doi.org/10.1002/14651858.CD010280.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010280-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010280-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010280-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010280-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010280-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010280-abs-0001" lang="en"> <section id="CD010280-sec-0001"> <h3 class="title" id="CD010280-sec-0001">Background</h3> <p>Allogeneic hematopoietic stem cell transplantation (allo‐HCT) is associated with improved outcomes for people with various hematologic diseases; however, the morbidity and mortality resulting from acute and subsequently chronic graft‐versus‐host disease (GVHD) pose a serious challenge to wider applicability of allo‐HCT. Intravenous methotrexate in combination with a calcineurin inhibitor, cyclosporine or tacrolimus, is a widely used regimen for the prophylaxis of acute GVHD, but the administration of methotrexate is associated with a number of adverse events. Mycophenolate mofetil, in combination with a calcineurin inhibitor, has been used extensively in people undergoing allo‐HCT. Conflicting results regarding various clinical outcomes following allo‐HCT have been observed when comparing mycophenolate mofetil‐based regimens against methotrexate‐based regimens for acute GVHD prophylaxis. </p> </section> <section id="CD010280-sec-0002"> <h3 class="title" id="CD010280-sec-0002">Objectives</h3> <p>Primary objective: to assess the effect of mycophenolate mofetil versus methotrexate for prevention of acute GVHD in people undergoing allo‐HCT. </p> <p>Secondary objectives: to evaluate the effect of mycophenolate mofetil versus methotrexate for overall survival, prevention of chronic GVHD, incidence of relapse, treatment‐related harms, nonrelapse mortality, and quality of life. </p> </section> <section id="CD010280-sec-0003"> <h3 class="title" id="CD010280-sec-0003">Search methods</h3> <p>We searched Cochrane Central Register of Controlled Trials (CENTRAL) and MEDLINE from inception to March 2014. We handsearched conference abstracts from the last two meetings (2011 and 2012) of relevant societies in the field. We searched ClinicalTrials.gov, Novartis clinical trials database (www.novctrd.com), Roche clinical trial protocol registry (www.roche‐trials.com), Australian New Zealand Clinical Trials Registry (ANZCTR), and the metaRegister of Controlled Trials for ongoing trials. </p> </section> <section id="CD010280-sec-0004"> <h3 class="title" id="CD010280-sec-0004">Selection criteria</h3> <p>Two review authors independently reviewed all titles/abstracts and selected full‐text articles for inclusion. We included all references that reported results of randomized controlled trials (RCTs) of mycophenolate mofetil versus methotrexate for the prophylaxis of GVHD among people undergoing allo‐HCT in this review. </p> </section> <section id="CD010280-sec-0005"> <h3 class="title" id="CD010280-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data on outcomes from all studies and compared prior to data entry and analysis. We expressed results as risk ratios (RR) and 95% confidence intervals (CI) for dichotomous outcomes and hazard ratios (HR) and 95% CIs for time‐to‐event outcomes. We pooled the individual study effects using the random‐effects model. Estimates lower than one indicate that mycophenolate mofetil was favored over methotrexate. </p> </section> <section id="CD010280-sec-0006"> <h3 class="title" id="CD010280-sec-0006">Main results</h3> <p>We included three trials enrolling 177 participants (174 participants analyzed). All participants in the trials by Keihl et al. and Bolwell et al. received cyclosporine while all participants enrolled in the trial by Perkins et al. received tacrolimus. However, the results did not differ by the type of calcineurin inhibitor employed (cyclosporine versus tacrolimus). There was no evidence for a difference between mycophenolate mofetil versus methotrexate for the outcomes of incidence of acute GVHD (RR 1.25; 95% CI 0.75 to 2.09; P value = 0.39, very low quality evidence), overall survival (HR 0.73; 95% CI 0.45 to 1.17; P value = 0.19, low‐quality evidence), median days to neutrophil engraftment (HR 0.77; 95% CI 0.51 to 1.17; P value = 0.23, low‐quality evidence), incidence of relapse (RR 0.84; 95% CI 0.52 to 1.38; P value = 0.50, low‐quality evidence), non‐relapse mortality (RR 1.21; 95% CI 0.62 to 2.36; P value = 0.57, low‐quality evidence), and incidence of chronic GVHD (RR 0.92; 95% CI 0.65 to 1.30; P value = 0.62, low‐quality evidence). There was low‐quality evidence that mycophenolate mofetil compared with methotrexate improved platelet engraftment period (HR 0.87; 95% CI 0.81 to 0.93; P value &lt; 0.0001, low‐quality evidence). There was low‐quality evidence that mycophenolate mofetil compared with methotrexate resulted in decreased incidence of severe mucositis (RR 0.48; 95% CI 0.32 to 0.73; P value = 0.0006, low‐quality evidence), use of parenteral nutrition (RR 0.48; 95% CI 0.26 to 0.91; P value = 0.02, low‐quality evidence), and medication for pain control (RR 0.76; 95% CI 0.63 to 0.91; P value = 0.002, low‐quality evidence). Overall heterogeneity was not detected in the analysis except for the outcome of neutrophil engraftment. None of the included studies reported any outcomes related to quality of life. Overall quality of evidence was low. </p> </section> <section id="CD010280-sec-0007"> <h3 class="title" id="CD010280-sec-0007">Authors' conclusions</h3> <p>The use of mycophenolate mofetil compared with methotrexate for primary prevention of GVHD seems to be associated with a more favorable toxicity profile, without an apparent compromise on disease relapse, transplant‐associated mortality, or overall survival. The effects on incidence of GVHD between people receiving mycophenolate mofetil compared with people receiving methotrexate were uncertain. There is a need for additional high‐quality RCTs to determine the optimal GVHD prevention strategy. Future studies should take into account a comprehensive view of clinical benefit, including measures of morbidity, symptom burden, and healthcare resource utilization associated with interventions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010280-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010280-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010280-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010280-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010280-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010280-abs-0004" lang="en"> <h3>Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease following allogeneic hematopoietic stem cell transplantation </h3> <p><b>Background</b> </p> <p>Allogeneic hematopoietic stem cell transplantation is a procedure in which a portion of a healthy donor's stem cells (cells that can develop into various types of blood cells) or bone marrow is obtained and prepared for intravenous infusion. Hematopoietic stem cells are taken from a healthy donor and transplanted into the patient (recipient). People undergoing allogeneic hematopoietic stem cell transplantation are at risk of developing graft‐versus‐host disease (GVHD). GVHD results when the transplanted cells from the donor (graft) attack the recipient's (host) body cells because they perceive the recipient's body as foreign. Mycophenolate mofetil and methotrexate are two drugs often used to suppress the human body's reaction against the graft (immune response) and prevent GVHD. We conducted a systematic review of three randomized controlled trials (RCTs, which are clinical studies where people are randomly put into one of two or more treatment groups) that compared mycophenolate mofetil versus methotrexate for use in preventing GVHD among 174 participants. We searched for the relevant studies in March 2014. </p> <p><b>Study characteristics</b> </p> <p>All participants in these RCTs received a drug aimed at suppressing the immune response (cyclosporine or tacrolimus). The study by Perkins and coworkers was funded by public and industry sources. The study by Kiehl and coworkers was funded by public sources. The funding source for the study by Bolwell and coworkers was not specified. </p> <p><b>Key results</b> </p> <p>Our results show no clinically meaningful difference between mycophenolate mofetil and methotrexate on length of survival, incidence of GVHD, disease relapse, or treatment‐related death. People treated with mycophenolate mofetil had a shorter time to make new platelets (cells that help the blood to clot) from the donor cells compared with people treated with methotrexate. In addition, in terms of side effects, people treated with mycophenolate mofetil were less likely to have severe mucositis (inflammation of the mucus membranes), require parenteral nutrition (feeding through a vein), or pain medication. </p> <p>None of the included studies reported any data related to quality of life.</p> <p>In summary, mycophenolate mofetil and methotrexate both remain acceptable medications for the prevention of GVHD; however, mycophenolate mofetil seems to be associated with a smaller incidence of harms such as severe mucositis and related supportive care. </p> <p><b>Quality of evidence</b> </p> <p>The overall quality of evidence was low.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010280-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010280-sec-0084"></div> <h3 class="title" id="CD010280-sec-0085">Implications for practice</h3> <section id="CD010280-sec-0085"> <p>The findings of this analysis suggest that mycophenolate mofetil is an acceptable agent when used in combination with a calcineurin inhibitor for primary prevention of graft‐versus‐host disease (GVHD). Treating clinicians can anticipate a beneficial reduction in severe mucositis and its associated supportive care in comparison with the use of methotrexate plus a calcineurin inhibitor. There was no clinically meaningful difference in the incidence of GVHD, disease relapse, transplant‐associated mortality, or overall survival between people receiving mycophenolate mofetil and people receiving methotrexate. </p> </section> <h3 class="title" id="CD010280-sec-0086">Implications for research</h3> <section id="CD010280-sec-0086"> <p>This analysis suggests the following implications for future research. First, there is a need for additional high‐quality randomized controlled trials to address the optimal GVHD prevention strategy among people receiving allogeneic hematopoietic stem cell transplantation. Second, this analysis demonstrated that future studies should take into account a comprehensive view of clinical benefit, including measures of morbidity, symptom burden, and healthcare resource utilization associated with interventions. In addition to clinical outcomes, future studies should consider reporting quality of life. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010280-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010280-sec-0022"></div> <div class="table" id="CD010280-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving allogeneic hematopoietic stem cell transplantation<br/> <b>Settings:</b> inpatients/hospital<br/> <b>Intervention:</b> mycophenolate mofetil versus methotrexate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Methotrexate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Mycophenolate mofetil </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Overall survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HR 0.73</b> </p> <p>(0.45 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Prevention of acute GVHD grade II to IV</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.25</b> <br/> (0.75 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>174<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>595 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>744 per 1000</b> <br/> (446 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>368 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>460 per 1000</b> <br/> (276 to 769) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.84</b> <br/> (0.52 to 1.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>348 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>293 per 1000</b> <br/> (181 to 481) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>386 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>324 per 1000</b> <br/> (201 to 533) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Nonrelapse mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.21</b> <br/> (0.62 to 2.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>89<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (158 to 603) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (158 to 602) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Prevention of chronic GVHD</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.92</b> <br/> (0.65 to 1.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>460 per 1000</b> <br/> (325 to 650) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>496 per 1000</b> <br/> (350 to 701) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of severe mucositis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.48</b> <br/> (0.32 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>174<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>557 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>267 per 1000</b> <br/> (178 to 407) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>278 per 1000</b> <br/> (185 to 423) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Use of total parenteral nutrition</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.48</b> <br/> (0.26 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>606 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>291 per 1000</b> <br/> (158 to 552) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>614 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>295 per 1000</b> <br/> (160 to 559) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of narcotic use for pain control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.76</b> <br/> (0.63 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>909 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>691 per 1000</b> <br/> (573 to 827) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>921 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>700 per 1000</b> <br/> (580 to 838) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>GVHD:</b> graft‐versus‐host disease; <b>HR:</b> hazard ratio; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only one of the included articles described an adequate method of generation of randomization sequence and reported an adequate concealment of the sequence of allocation (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The trials conducted by Kiehl et al. and Perkins et al. were open‐label trials.<br/> <sup>2</sup> The pooled estimate has wide confidence intervals, which reflects lower precision of the estimate.<br/> <sup>3</sup> Only three RCTs are published comparing mycophenolate mofetil versus methotrexate which reflects potential publication bias.<br/> <sup>4</sup> Data were reported in only one RCT. </p> <p><sup>5</sup> Generated by GRADEpro software based on event rate in the control arm of included studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010280-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010280-sec-0023"></div> <p>Allogeneic hematopoietic stem cell transplantation (allo‐HCT) is associated with improved outcomes for people with various hematologic diseases (<a href="./references#CD010280-bbs2-0012" title="BensingerW . Individual patient data meta‐analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration. Bone Marrow Transplantation2006;38(8):539‐46. [PUBMED: 16953207] ">Bensinger 2006</a>; <a href="./references#CD010280-bbs2-0030" title="Kharfan‐DabajaMA , PidalaJ , KumarA , TerasawaT , DjulbegovicB . Comparing efficacy of reduced‐toxicity allogeneic hematopoietic cell transplantation with conventional chemo‐(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis. Bone Marrow Transplantation2012;47(9):1164‐70. [PUBMED: 22562081] ">Kharfan‐Dabaja 2012</a>; <a href="./references#CD010280-bbs2-0034" title="KorethJ , SchlenkR , KopeckyKJ , HondaS , SierraJ , DjulbegovicBJ , et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta‐analysis of prospective clinical trials. JAMA2009;301(22):2349‐61. [PUBMED: 19509382] ">Koreth 2009</a>). Despite improved understanding of the pathophysiology of acute graft‐versus‐host disease (GVHD) and introduction of newer immunosuppressive agents, the morbidity and mortality resulting from acute and subsequently chronic GVHD pose a serious challenge to wider applicability of allo‐HCT (<a href="./references#CD010280-bbs2-0017" title="FerraraJL , LevineJE , ReddyP , HollerE . Graft‐versus‐host disease. Lancet2009;373(9674):1550‐61. [PUBMED: 19282026] ">Ferrara 2009</a>). Effects of allo‐HCT are particularly significant when we consider that an increasing number of allo‐HCTs are being performed in populations with known risk factors for development of acute or chronic GVHD (<a href="./references#CD010280-bbs2-0019" title="FlowersME , InamotoY , CarpenterPA , LeeSJ , KiemHP , PetersdorfEW , et al. Comparative analysis of risk factors for acute graft‐versus‐host disease and for chronic graft‐versus‐host disease according to National Institutes of Health consensus criteria. Blood2011;117(11):3214‐9. [PUBMED: 21263156] ">Flowers 2011</a>; <a href="./references#CD010280-bbs2-0033" title="KollmanC , HoweCW , AnasettiC , AntinJH , DaviesSM , FilipovichAH , et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood2001;98(7):2043‐51. [PUBMED: 11567988] ">Kollman 2001</a>). Specifically, more people are receiving unrelated donor hematopoietic stem cells, which are either human leukocyte antigen (HLA)‐matched or mismatched, and more older people who generally receive stem cell allografts from older siblings are undergoing allo‐HCT (<a href="./references#CD010280-bbs2-0019" title="FlowersME , InamotoY , CarpenterPA , LeeSJ , KiemHP , PetersdorfEW , et al. Comparative analysis of risk factors for acute graft‐versus‐host disease and for chronic graft‐versus‐host disease according to National Institutes of Health consensus criteria. Blood2011;117(11):3214‐9. [PUBMED: 21263156] ">Flowers 2011</a>; <a href="./references#CD010280-bbs2-0033" title="KollmanC , HoweCW , AnasettiC , AntinJH , DaviesSM , FilipovichAH , et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood2001;98(7):2043‐51. [PUBMED: 11567988] ">Kollman 2001</a>). </p> <section id="CD010280-sec-0024"> <h3 class="title" id="CD010280-sec-0024">Description of the condition</h3> <p>Acute GVHD is a clinico‐pathologic syndrome that affects a significant proportion of allo‐HCT recipients. Approximately 35% to 50% of people undergoing allo‐HCT are expected to develop grade II to IV acute GVHD (<a href="./references#CD010280-bbs2-0029" title="JacobsohnDA , VogelsangGB . Acute graft versus host disease. Orphanet Journal of Rare Diseases2007;2:35. [PUBMED: 17784964] ">Jacobsohn 2007</a>). This syndrome is driven by alloreactive donor T cells that recognize disparate minor histocompatibility antigens. Organs targeted by acute GVHD are largely the skin, liver, and gastrointestinal tract. Diagnosis is made on a clinical basis, but confirmatory pathologic findings on tissue biopsy can help to confirm clinical diagnosis. Severity of the syndrome is associated with increased risk of mortality. Despite pharmacologic immune suppression prophylaxis, many people will still develop the syndrome and experience the attendant morbidity and mortality. The established primary therapy of high‐dose prednisone offers complete remission in 30% to 50% of cases; however, people with steroid‐refractory acute GVHD have poor long‐term survival (<a href="./references#CD010280-bbs2-0038" title="PidalaJ , AnasettiC . Glucocorticoid‐refractory acute graft‐versus‐host disease. Biology of Blood and Marrow Transplantation2010;16(11):1504‐18. [PUBMED: 20096359] ">Pidala 2010</a>). </p> <p>While severe acute GVHD is a major source of early post‐allo‐HCT mortality, chronic GVHD constitutes a major threat in terms of late HCT‐associated morbidity, impaired quality of life, symptom burden, disability, and mortality. The majority of people alive beyond 100 days post‐HCT will develop chronic GVHD. In contrast to acute GVHD, chronic GVHD has protean manifestations, many of which have parallels to allied human immune‐mediated disorders. The most commonly involved organ sites are the skin, mouth, eyes, and liver. Following a 2005 National Institutes of Health (NIH) Consensus Conference, major changes were proposed to the diagnosis, classification, and severity scoring of the syndrome (<a href="./references#CD010280-bbs2-0018" title="FilipovichAH ,  WeisdorfD ,  PavleticS ,  SocieG ,  WingardJR ,  LeeSJ ,  etal . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft‐versus‐host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation2005;11(12):945‐56. [PUBMED: 16338616] ">Filipovich 2005</a>). It is distinguished from acute GVHD by the diagnosis of chronic GVHD manifestations and is not based solely on the time from allo‐HCT. The previously used limited/extensive severity classification (<a href="./references#CD010280-bbs2-0042" title="ShulmanHM ,  SullivanKM ,  WeidenPL ,  McDonaldGB ,  StrikerGE ,  SaleGE ,  etal . Chronic graft‐versus‐host syndrome in man. A long‐term clinicopathologic study of 20 Seattle patients. American Journal of Medicine1980;69(2):204‐17. [PUBMED: 6996481] ">Shulman 1980</a>) has also been replaced by a scoring system that takes into account the number and severity of organs involved to produce a global score of mild, moderate, or severe.(<a href="./references#CD010280-bbs2-0018" title="FilipovichAH ,  WeisdorfD ,  PavleticS ,  SocieG ,  WingardJR ,  LeeSJ ,  etal . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft‐versus‐host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation2005;11(12):945‐56. [PUBMED: 16338616] ">Filipovich 2005</a>) </p> <p>Currently, the evidence supports high‐dose prednisone as primary therapy, but this has limited effectiveness, with most affected people requiring second‐line immune suppressive therapy to control the syndrome. </p> <p>As survival rates associated with acute GVHD have increased over the past decades, so also have the costs associated with treatment (<a href="./references#CD010280-bbs2-0046" title="SvahnBM , RingdenO , RembergerM . Treatment costs and survival in patients with grades III‐IV acute graft‐versus‐host disease after allogenic hematopoietic stem cell transplantation during three decades. Transplantation2006;81(11):1600‐3. [PUBMED: 16770251] ">Svahn 2006</a>). One review by Khera et al. found the costs of allo‐HCT to range from USD 96,000 to USD 204,000 in 2012 and multiple studies agree that major drivers of these costs are post‐transplantation complications such as acute GVHD (<a href="./references#CD010280-bbs2-0031" title="KheraN , ZeliadtSB , LeeSJ . Economics of hematopoietic stem cell transplantation. Blood2012;120(8):1545‐51. [PUBMED: 22700725] ">Khera 2012</a>; <a href="./references#CD010280-bbs2-0047" title="SvahnBM , RembergerM , AlvinO , KarlssonH , RingdenO . Increased costs after allogeneic haematopoietic SCT are associated with major complications and re‐transplantation. Bone Marrow Transplantation2012;47(5):706‐15. [PUBMED: 21874063] ">Svahn 2012</a>). Developing effective regimens for the prevention of both acute and chronic GVHD is of paramount importance due to the risk of morbidity and mortality associated with established GVHD and its adverse impact on patient symptom burden, functional ability, and quality of life. </p> </section> <section id="CD010280-sec-0025"> <h3 class="title" id="CD010280-sec-0025">Description of the intervention</h3> <p>As of 2014, no single acute GVHD prophylaxis regimen is considered the standard of care. Intravenous (IV) methotrexate in combination with a calcineurin inhibitor, cyclosporine or tacrolimus, is a widely used regimen for the prophylaxis of acute GVHD. However, administration of methotrexate is associated with a number of adverse events such as severe mucositis, delayed hematopoietic recovery, and organ toxicity (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0013" title="CutlerC , LiS , KimHT , LaglenneP , SzetoKC , HoffmeisterL , et al. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate‐ and non‐methotrexate‐containing graft‐versus‐host disease prophylaxis regimens. Biology of Blood and Marrow Transplantation2005;11(5):383‐8. [PUBMED: 15846292] ">Cutler 2005</a>; <a href="./references#CD010280-bbs2-0004" title="NeumannF ,  GraefT ,  TapprichC ,  VaupelM ,  SteidlU ,  GermingU ,  etal . Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft‐versus‐host disease prophylaxis after stem cell transplantation from HLA‐identical siblings. Bone Marrow Transplantation2005;35(11):1089‐93. [PUBMED: 15821769] ">Neumann 2005</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>; <a href="./references#CD010280-bbs2-0039" title="PinanaJL , ValcarcelD , Fernandez‐AvilesF , MartinoR , RoviraM , BarbaP , et al. MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced‐intensity conditioning PBSCT from HLA‐identical siblings. Bone Marrow Transplantation2010;45(9):1449‐56. [PUBMED: 20140024] ">Pinana 2010</a>). </p> </section> <section id="CD010280-sec-0026"> <h3 class="title" id="CD010280-sec-0026">How the intervention might work</h3> <p>Mycophenolate mofetil is an ester prodrug of mycophenolic acid and a known inhibitor of inosine monophosphate dehydrogenase. By inhibition of de novo purine biosynthesis, mycophenolate mofetil selectively targets activated lymphocytes and suppresses the primary antibody response (<a href="./references#CD010280-bbs2-0010" title="AllisonAC , EuguiEM . Mycophenolate mofetil and its mechanisms of action. Immunopharmacology2000;47(2‐3):85‐118. [PUBMED: 10878285] ">Allison 2000</a>). In canine models, investigators have established that stable mixed chimeras, organisms composed of a mixture of two or more genetically distinct cells, are achievable with administration of mycophenolate mofetil plus cyclosporine following a sublethal dose of total body irradiation and dog‐leukocyte antigen compatible marrow transplantation (<a href="./references#CD010280-bbs2-0045" title="StorbR , YuC , WagnerJL , DeegHJ , NashRA , KiemHP , et al. Stable mixed hematopoietic chimerism in DLA‐identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood1997;89(8):3048‐54. [PUBMED: 9108426] ">Storb 1997</a>; <a href="./references#CD010280-bbs2-0049" title="YuC , SeidelK , NashRA , DeegHJ , SandmaierBM , BarsoukovA , et al. Synergism between mycophenolate mofetil and cyclosporine in preventing graft‐versus‐host disease among lethally irradiated dogs given DLA‐nonidentical unrelated marrow grafts. Blood1998;91(7):2581‐7. [PUBMED: 9516160] ">Yu 1998</a>). </p> <p>Mycophenolate mofetil has been useful in preventing graft rejection in the field of organ transplantation. Specifically, it is effective in reducing GVHD among people undergoing kidney transplant, and has been evaluated in people undergoing heart, lung, and liver transplants (<a href="./references#CD010280-bbs2-0032" title="KnightSR , RussellNK , BarcenaL , MorrisPJ . Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation2009;87(6):785‐94. [PUBMED: 19300178] ">Knight 2009</a>; <a href="./references#CD010280-bbs2-0041" title="SchmedingM , KiesslingA , NeuhausR , HeidenhainC , BahraM , NeuhausP , et al. Mycophenolate mofetil monotherapy in liver transplantation: 5‐year follow‐up of a prospective randomized trial. Transplantation2011;92(8):923‐9. [PUBMED: 21832958] ">Schmeding 2011</a>; <a href="./references#CD010280-bbs2-0050" title="ZukDM , PearsonGJ . Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients ‐ a systematic review. Transplantation Reviews2009;23(3):171‐7. [PUBMED: 19345081] ">Zuk 2009</a>). In addition, mycophenolate mofetil, in combination with a calcineurin inhibitor, has been used extensively in people undergoing allo‐HCT. Several observational studies have evaluated the combination of mycophenolate mofetil with a calcineurin inhibitor as a possible alternative to methotrexate and shown this combination to be well tolerated in both nonmyeloablative and ablative settings with acceptable rates of GVHD (<a href="./references#CD010280-bbs2-0035" title="McSweeneyP , AbhyankarS , PetersenF . Tacrolimus and mycophenolate mofetil for GVHD prevention after unrelated donor transplants. Blood2003;102:2654a. ">McSweeney 2003</a>; <a href="./references#CD010280-bbs2-0036" title="NietoY , PattonN , HawkinsT , SpearingR , BearmanSI , JonesRB , et al. Tacrolimus and mycophenolate mofetil after nonmyeloablative matched‐sibling donor allogeneic stem‐cell transplantations conditioned with fludarabine and low‐dose total body irradiation. Biology of Blood and Marrow Transplantation2006;12(2):217‐25. [PUBMED: 16443519] ">Nieto 2006</a>; <a href="./references#CD010280-bbs2-0037" title="OsunkwoI , BessmertnyO , HarrisonL , CheungYK , Van deVenC , delToroG , et al. A pilot study of tacrolimus and mycophenolate mofetil graft‐versus‐host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biology of Blood and Marrow Transplantation2004;10(4):246‐58. [PUBMED: 15077223] ">Osunkwo 2004</a>). </p> </section> <section id="CD010280-sec-0027"> <h3 class="title" id="CD010280-sec-0027">Why it is important to do this review</h3> <p>Preference for a particular regimen, mycophenolate mofetil or methotrexate, for acute GVHD prophylaxis is largely based on uncontrolled, observational studies, and physician or transplant center preference. Conflicting results regarding various clinical outcomes following allo‐HCT have been observed when comparing mycophenolate mofetil‐based regimens against methotrexate‐based regimens for acute GVHD prophylaxis. These comparisons are further limited by the heterogeneity of participant, disease, and treatment‐related characteristics among studies. Heterogeneity is also introduced by donor and cell source, ablative intensity of preparative regimens, and dosing and schema of administration of acute GVHD prophylaxis agents. With an increasing number of allo‐HCTs being performed in people at high risk of developing acute GVHD, we believe it is important to evaluate the comparative efficacy of the two commonly used prophylactic agents, methotrexate versus mycophenolate mofetil, in the prevention of acute GVHD. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010280-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010280-sec-0028"></div> <p>Primary objective: to assess the effect of mycophenolate mofetil versus methotrexate for the prevention of acute GVHD in people undergoing allo‐HCT. </p> <p>Secondary objectives: to evaluate the effect of mycophenolate mofetil versus methotrexate for overall survival, prevention of chronic GVHD, incidence of relapse, treatment‐related harms, nonrelapse mortality, and quality of life. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010280-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010280-sec-0029"></div> <section id="CD010280-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010280-sec-0031"> <h4 class="title">Types of studies</h4> <p>We considered all prospective, randomized controlled trials (RCTs) of mycophenolate mofetil versus methotrexate utilizing a parallel study design for inclusion in this systematic review. We excluded all other study designs. </p> </section> <section id="CD010280-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included studies that enrolled participants who were at risk of developing GVHD as a result of undergoing allo‐HCT. We excluded studies that enrolled participants with an existing diagnosis of acute or chronic GVHD. We applied no restrictions on participant gender, ethnic group, or age. We described the disease type and stage of the included participants. </p> </section> <section id="CD010280-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Included studies reported on the direct comparison of any mycophenolate mofetil‐based regimen versus any methotrexate‐based regimen administered as prophylaxis for acute GVHD in people undergoing allo‐HCT. Specifically, we considered a regimen to be used as prophylaxis for acute GVHD if 1. the investigators specifically stated mycophenolate mofetil or methotrexate was used as prophylaxis for acute GVHD or 2. if the study inclusion/exclusion criteria excluded people with an existing diagnosis of acute or chronic GVHD. Supportive care and other GVHD prophylaxis/therapies, if any, were similar in both arms. In addition, since mycophenolate mofetil and methotrexate were commonly administered in combination with a calcineurin inhibitor (e.g. cyclosporine or tacrolimus), we included all regimens containing mycophenolate mofetil versus all regimens containing methotrexate, regardless of co‐therapies, in the review. </p> </section> <section id="CD010280-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD010280-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010280-list-0001"> <li> <p>Incidence of acute GVHD.</p> </li> <li> <p>Overall survival.</p> </li> </ol> </p> </section> <section id="CD010280-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010280-list-0002"> <li> <p>Engraftment kinetics evaluated as median days to neutrophil engraftment and median days to platelet engraftment. </p> </li> <li> <p>Incidence of relapse.</p> </li> <li> <p>Incidence of non‐relapse mortality (any death occurring without disease relapse/recurrence).</p> </li> <li> <p>Incidence of chronic GVHD.</p> </li> <li> <p>Quality of life (if measured using a validated tool for the assessment of quality of life). </p> </li> <li> <p>Any grade III or IV adverse events of treatment.</p> </li> <li> <p>Pain evaluated by incidence of narcotic use for pain control.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010280-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010280-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We conducted an electronic search of Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i>) using the search strategy in <a href="./appendices#CD010280-sec-0090">Appendix 1</a> and MEDLINE using search strategy in <a href="./appendices#CD010280-sec-0091">Appendix 2</a> from inception to 17 March 2014. We applied no date or language limits. </p> </section> <section id="CD010280-sec-0039"> <h4 class="title">Searching other resources</h4> <p>In order to identify any recently completed studies that had not been published in full, we searched conference abstracts from the last two meetings (2011 and 2012) of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), European Group of Blood and Marrow Transplantation (EBMT), and BMT tandem meetings of the American Society of Blood and Marrow Transplantation (ASABM), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Hematology Association (EHA). We also handsearched references of all identified review articles and included studies. In order to identify unpublished or ongoing studies, we searched ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>), Novartis Clinical Trial Results Database (<a href="http://www.novctrd.com" target="_blank">www.novctrd.com</a>), Roche Clinical Trial Protocol Registry (<a href="http://www.roche-trials.com" target="_blank">www.roche‐trials.com</a>), Australian New Zealand Clinical Trials Registry (ANZCTR), and the metaRegister of Controlled Trials. </p> </section> </section> <section id="CD010280-sec-0040"> <h3 class="title" id="CD010280-sec-0040">Data collection and analysis</h3> <section id="CD010280-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (RM and TR) reviewed all titles, abstracts, and full‐text reports independently. We included studies that met the following criteria in the review. </p> <p> <ol id="CD010280-list-0003"> <li> <p>Prospective clinical trial.</p> </li> <li> <p>Parallel study design.</p> </li> <li> <p>Participants randomized to prophylaxis with mycophenolate mofetil versus methotrexate.</p> </li> <li> <p>Participants undergoing allo‐HCT.</p> </li> </ol> </p> <p>We matched references on author names, location and setting, specific intervention details, and participants to avoid inclusion of duplicate publications. We resolved any disagreements between review authors during the study selection by consensus with a third review author (MAK‐D or AK). </p> </section> <section id="CD010280-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data according to Chapter 7 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using a standardized data extraction form containing the following items (<a href="./references#CD010280-bbs2-0026" title="HigginsJPT , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>): </p> <p> <ul id="CD010280-list-0004"> <li> <p>general information: study title, authors, source;</p> </li> <li> <p>study characteristics: study design, setting, duration of follow‐up;</p> </li> <li> <p>participant characteristics: number of participants enrolled, number of participants included in the analysis, specific disease diagnosis, donor status (related or unrelated donor), HLA‐mismatch, participant age; </p> </li> <li> <p>interventions: name, dose, route, administration schedule, and associated therapies;</p> </li> <li> <p>outcomes: incidence of acute GVHD (grades II to IV and III to IV GVHD), overall survival, median days to neutrophil engraftment, median days to platelet engraftment, incidence of relapse, incidence of chronic GVHD, grade III or IV adverse events, nonrelapse mortality (any death occurring without disease relapse/recurrence), pain; </p> </li> <li> <p>risk of bias.</p> </li> </ul> </p> <p>For studies that had multiple publications, we used the publication with longest follow‐up for extracting data on outcomes. We used earlier publications to extract data on methodology and baseline characteristics. In cases where the method of analysis was not specified by the investigators and only the number of events was reported, we used the number randomized as the denominator. That is, we recorded results according to intention‐to‐treat (ITT) analysis. </p> </section> <section id="CD010280-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (RM and TR) independently assessed the risk of bias in the included studies using The Cochrane Collaboration's tool for assessing the risk of bias as outlined in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> based on extracted information (<a href="./references#CD010280-bbs2-0027" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). A third author (MAK‐D or AK) resolved any disagreements between the two review authors. In addition to risk of bias, we evaluated the risk of random error by extracting data on the investigator's predetermined effect difference, alpha, power, and sample size. </p> <p>Specifically, for assessment of risk of bias, we graded each component of methodologic quality as low, high, or unclear. We evaluated selection bias by assessing the investigators' description of method of randomization and allocation concealment. The method of randomization was: </p> <p> <ul id="CD010280-list-0005"> <li> <p>low risk if the investigators described a random component in the sequence generation process (i.e. refer to a random number table, use a computer random number generator, coin toss); </p> </li> <li> <p>high risk if the investigators described a nonrandom component in the sequence generation process (sequence generated by odd or even date of birth, some rule based on date (or day) of admission, or some rule based on hospital or clinic record number); and </p> </li> <li> <p>unclear risk if there was insufficient information about the sequence generation process to permit judgment of 'low risk' or 'high risk'. </p> </li> </ul> </p> <p>We considered allocation concealment to be:</p> <p> <ul id="CD010280-list-0006"> <li> <p>low risk if participants and investigators enrolling participants could not foresee assignment (i.e. use of central allocation, sequentially numbered identical drug containers or sequentially numbered, opaque, sealed envelopes); </p> </li> <li> <p>high risk if participants or investigators enrolling participants could possibly foresee assignments (allocation based on date of birth, case record number, using an open random allocation schedule); and </p> </li> <li> <p>unclear risk if there was insufficient information to permit judgment of 'low risk' or 'high risk'. </p> </li> </ul> </p> <p>We evaluated performance bias by assessing the investigators' description of blinding of participants and investigators. Performance bias was: </p> <p> <ul id="CD010280-list-0007"> <li> <p>low risk if no blinding was used, but the outcome was not likely to be influenced by lack of blinding or participants and key study personnel were blinded; </p> </li> <li> <p>high risk if no blinding or incomplete blinding was used, and the outcome was likely to be influenced by lack of blinding; and </p> </li> <li> <p>unclear risk if there was insufficient information to permit judgment of 'low risk' or 'high risk'. </p> </li> </ul> </p> <p>We judged detection bias due to knowledge of the allocated interventions by outcome assessors to be: </p> <p> <ul id="CD010280-list-0008"> <li> <p>low risk if no blinding of outcome assessment was used, but the outcome measurement was not likely to be influenced by lack of blinding or blinding of outcome assessment was ensured; </p> </li> <li> <p>high risk if there was no blinding of outcome assessment, and the outcome measurement was likely to be influenced by lack of blinding; and </p> </li> <li> <p>unclear risk if there was insufficient information to permit judgment of 'low risk' or 'high risk'.  </p> </li> </ul> </p> <p>We judged attrition bias due to the amount, nature, or handling of incomplete outcome data to be: </p> <p> <ul id="CD010280-list-0009"> <li> <p>low risk if there were no missing outcome data, reasons for missing outcome data were unlikely to be related to true outcome, or missing outcome data were balanced in numbers across intervention groups, with similar reasons for missing data across groups; </p> </li> <li> <p>high risk if the reasons for missing outcome data were likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups. For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce clinically relevant bias in the intervention effect estimate, or uses 'as‐treated' analysis with substantial departure of the intervention received from that assigned at randomization or uses potentially inappropriate application of simple imputation; </p> </li> <li> <p>unclear risk if there was insufficient reporting of attrition/exclusions to permit judgment of 'low risk' or 'high risk' (e.g. number randomized not stated, no reasons for missing data provided). </p> </li> </ul> </p> <p>We considered reporting bias due to selective outcome reporting to be:</p> <p> <ul id="CD010280-list-0010"> <li> <p>low risk if the study protocol was available and all of the study's prespecified (primary and secondary) outcomes that were of interest in the review had been reported in the prespecified way or the study protocol was not available but it was clear that the published reports included all expected outcomes, including those that were prespecified; </p> </li> <li> <p>high risk if the study's prespecified primary outcomes had not been reported, primary outcomes were reported using measurements that were not prespecified, primary outcomes were not prespecified, outcomes of interest in the review were reported incompletely so that they could not be entered in a meta‐analysis, or the study report did not include results for a key outcome that would be expected to have been reported for such a study; and </p> </li> <li> <p>unclear if there was insufficient information to permit judgment of 'low risk' or 'high risk'. </p> </li> </ul> </p> <p>For the evaluation of risk or random error, we captured whether investigators report predetermined effect difference, alpha, power, and sample size calculation (yes/no and reported values) and if they were able to enroll the prespecified number of participants (prespecified sample size versus total number enrolled per arm). </p> </section> <section id="CD010280-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <section id="CD010280-sec-0045"> <h5 class="title">Dichotomous data</h5> <p>We summarized dichotomous data (i.e. incidence of acute/chronic GVHD, incidence of relapse, nonrelapse mortality, adverse events, narcotic use) using risk ratio (RR) pooled using the random‐effects model and reported with 95% confidence intervals (CI). </p> </section> <section id="CD010280-sec-0046"> <h5 class="title">Time‐to‐event data</h5> <p>In cases of time‐to‐event data (i.e. overall survival and days to neutrophil/platelet engraftment), for each included study we calculated the observed minus expected events (O minus E) and variance from the reported time‐to‐event estimates to obtain the log hazard ratio (LnHR) and standard error (SE) of LnHR for imputation using Review Manager 5 (<a href="./references#CD010280-bbs2-0040" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). In cases where time‐to‐event estimates were not reported, we extracted data from papers using the methods described by Tierney et al. (<a href="./references#CD010280-bbs2-0048" title="TierneyJ , StewartL , GhersiD , BurdettS , SydesM . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8(1):1‐16. ">Tierney 2007</a>). This method allowed calculation of the hazard ratio (HR) from different parameters using indirect calculation of the variance and the number of O minus E events. We pooled time‐to‐event estimates using the random‐effects model and reported with 95% CI using the generic inverse variance method. </p> </section> </section> <section id="CD010280-sec-0047"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis for this review was individual study. In the case of repeated follow‐up (e.g. reporting of survival at three and six months), we used the longest follow‐up from each study. We treated recurring events (e.g. adverse events) as a single event occurring in one participant (e.g. we considered four instances of nausea in one participant as one participant with nausea). In the case of multiple intervention arms, we combined arms together to create a single pair‐wise comparison. </p> </section> <section id="CD010280-sec-0048"> <h4 class="title">Dealing with missing data</h4> <p>As suggested in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010280-bbs2-0028" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>), in the case of missing outcome data, we attempted to contact the principal investigator or corresponding author (or both) of the study. If the corresponding author was unable to provide the missing data for an outcome, we included the study in the systematic review but excluded it from the meta‐analysis for the outcome with missing data. We undertook no imputation of missing individual participant data. </p> </section> <section id="CD010280-sec-0049"> <h4 class="title">Assessment of heterogeneity</h4> <p>To evaluate heterogeneity between pooled studies, we calculated the Chi<sup>2</sup> and I<sup>2</sup> statistics (<a href="./references#CD010280-bbs2-0014" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). We considered an I<sup>2</sup> statistic &gt; 50% to indicate substantial heterogeneity or a Chi<sup>2</sup> test with a significance level at P value &lt; 0.1 to indicate statistically significant heterogeneity. </p> </section> <section id="CD010280-sec-0050"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess publication bias using a funnel plot if more than 10 studies were included in the review (<a href="./references#CD010280-bbs2-0016" title="EggerM , SmithDG , SchniderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315:629‐34. ">Egger 1997</a>; <a href="./references#CD010280-bbs2-0044" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). We evaluated selective reporting of outcomes within studies by comparing outcomes reported with outcomes specified in protocols, when available. </p> </section> <section id="CD010280-sec-0051"> <h4 class="title">Data synthesis</h4> <p>We performed pooled analysis using Review Manager 5 (<a href="./references#CD010280-bbs2-0040" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). We employed a random‐effects model using the DerSimonian‐Laird approach to pool studies for all analyses (<a href="./references#CD010280-bbs2-0015" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177‐88. ">DerSimonian 1986</a>). </p> <p>We constructed a 'Summary of findings' table using the most clinically and participant‐relevant outcomes (<a href="./references#CD010280-bbs2-0020" title="GuyattG , OxmanAD , AklE , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011</a>). These outcomes included: overall survival, incidence of relapse, incidence of grade II to IV acute GVHD, incidence of chronic GVHD, nonrelapse mortality, and incidence of any grade III to IV adverse events. In addition, we evaluated and reported the quality of evidence for each outcome according to GRADE guidelines (<a href="./references#CD010280-bbs2-0011" title="BalshemH , HelfandM , SchunemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines 3: rating the quality of evidence ‐ introduction. Journal of Clinical Epidemiology2011;64(4):401‐6. [PUBMED: 21208779] ">Balshem 2011</a>; <a href="./references#CD010280-bbs2-0021" title="GuyattGH , OxmanAD , VistG , KunzR , BrozekJ , Alonso‐CoelloP , et al. GRADE guidelines: 4. Rating the quality of evidence ‐ risk of bias. Journal of Clinical Epidemiology2011;64(4):407‐15. [PUBMED: 21247734] ">Guyatt 2011a</a>; <a href="./references#CD010280-bbs2-0022" title="GuyattGH , OxmanAD , MontoriV , VistG , KunzR , BrozekJ , et al. GRADE guidelines: 5. Rating the quality of evidence ‐ publication bias. Journal of Clinical Epidemiology2011;64(12):1277‐82. [PUBMED: 21802904] ">Guyatt 2011b</a>; <a href="./references#CD010280-bbs2-0023" title="GuyattG , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines: 6. Rating the quality of evidence ‐ imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [PUBMED: 21839614] ">Guyatt 2011c</a>; <a href="./references#CD010280-bbs2-0024" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence ‐ inconsistency. Journal of Clinical Epidemiology2011;64(12):1294‐302. [PUBMED: 21803546] ">Guyatt 2011d</a>; <a href="./references#CD010280-bbs2-0025" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 8. Rating the quality of evidence ‐ indirectness. Journal of Clinical Epidemiology2011;64(12):1303‐10. [PUBMED: 21802903] ">Guyatt 2011e</a>). </p> </section> <section id="CD010280-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Originally we planned to conduct subgroup analyses on prognostically relevant factors including gender, age (adult versus child), disease stage, previous treatment, differences in therapy regimen (co‐therapies), remission status prior to conditioning (complete remission), and type of donor (sibling versus unrelated). However, due to the small number of studies identified and lack of reporting by subgroup, we did not perform any subgroup analyses. </p> </section> <section id="CD010280-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>Originally we planned to conduct a sensitivity analysis on all aspects of methodological quality. Due to the small number of studies identified by this systematic review, we have not performed any sensitivity analyses proposed in the protocol. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010280-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010280-sec-0054"></div> <section id="CD010280-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD010280-sec-0056"> <h4 class="title">Results of the search</h4> <p>The electronic search retrieved 263 references and the abstract search retrieved 609 references. In all, we screened 841 unique references by title and abstract. Of these, we selected 25 references for full‐text review. Three studies met the inclusion criteria. Selection flow diagram and reasons for exclusion are provided in <a href="#CD010280-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010280-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010280-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010280-sec-0057"> <h4 class="title">Included studies</h4> <p>The review includes three studies (see <a href="./references#CD010280-sec-0099" title="">Characteristics of included studies</a>) (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). </p> <p>The study by Kiehl et al. was a multicenter RCT comparing GVHD prophylaxis among three treatment arms; mycophenolate mofetil twice daily at 1 g per dose IV for the duration of the study; mycophenolate mofetil twice daily at 1.5 g per dose IV for the duration of the study; and methotrexate on days one, three, and six (total dose on day one was 15 mg IV, and on days three and six was 10 mg IV for the duration of the study). In addition to randomized treatment, all participants received cyclosporine and prednisolone supportive care. Cyclosporine was begun on day +1 and adjusted to trough plasma levels of 250 to 300 ng/L. At the time of publication of interim findings, 45 participants were randomized to receive either the methotrexate‐containing regimen or mycophenolate mofetil in a dosage of 1 g twice daily or 1.5 g twice daily IV. Eligible participants had received stem cells from a mismatched related or a mismatched or a matched unrelated donor. (<a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>). The results of the two mycophenolate mofetil arms in this study were pooled for this review. </p> <p>In the study by Bolwell et al., participants were prospectively randomized 1:1 to receive either cyclosporine plus mycophenolate mofetil or cyclosporine plus methotrexate for GVHD prophylaxis. All participants were required to have a 6/6 HLA‐matched related donor. All donors were required to undergo a bone marrow harvest. Study end points included the incidence of acute GVHD, severity of mucositis, time to engraftment of neutrophils and platelets, and 100‐day survival. In this study, 21 participants received mycophenolate mofetil and 19 participants received methotrexate (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>). </p> <p>The study by Perkins et al. was a single‐center, randomized phase II trial comparing tacrolimus plus mycophenolate mofetil versus tacrolimus plus methotrexate. ITT analysis included 42 participants randomized to tacrolimus plus mycophenolate mofetil and 47 participants randomized to tacrolimus plus methotrexate (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). </p> <p>In summary, two RCTs used cyclosporine as the calcineurin inhibitor (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>), and one RCT used tacrolimus as the calcineurin inhibitor (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The results did not differ based on the type of the calcineurin inhibitor. See <a href="./references#CD010280-sec-0099" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD010280-sec-0058"> <h4 class="title">Excluded studies</h4> <p>We excluded four observational studies that reported data on mycophenolate mofetil versus methotrexate because they were not RCTs (<a href="./references#CD010280-bbs2-0004" title="NeumannF ,  GraefT ,  TapprichC ,  VaupelM ,  SteidlU ,  GermingU ,  etal . Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft‐versus‐host disease prophylaxis after stem cell transplantation from HLA‐identical siblings. Bone Marrow Transplantation2005;35(11):1089‐93. [PUBMED: 15821769] ">Neumann 2005</a>; <a href="./references#CD010280-bbs2-0005" title="OstronoffF ,  OstronoffM ,  Souto‐MaiorAP ,  DominguesM ,  SucupiraA ,  MansoDA ,  etal . Prospective trial of mycophenolate mofetil‐cyclosporine A prophylaxis for acute GVHD after G‐CSF stimulated allogeneic bone marrow transplantation with HLA‐identical sibling donors in patients with severe aplastic anemia and hematological malignancies. Clinical Transplantation2009;23(1):33‐8. [PUBMED: 18727660] ">Ostronoff 2009</a>; <a href="./references#CD010280-bbs2-0006" title="PiñanaJL ,  ValcárcelD ,  Fernández‐AvilésF ,  MartinoR ,  RoviraM ,  BarbaP ,  etal . MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced‐intensity conditioning PBSCT from HLA‐identical siblings. Bone Marrow Transplantation2010;45(9):1449‐56. [PUBMED: 20140024] ">Piñana 2010</a>; <a href="./references#CD010280-bbs2-0007" title="WangJ ,  SongX ,  ZhangW ,  TongS ,  HouJ ,  ChenL ,  etal . Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation. Zhonghua Yi Xue Za Zhi2002;82(8):507‐10. [PUBMED: 12133492] ">Wang 2002</a>). These four studies were included in the eight non‐randomized trials excluded at the full‐text manuscript phase. We have chosen to specifically report these four since they resemble our included studies more closely than the rest of the excluded studies. See <a href="./references#CD010280-sec-0100" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD010280-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>Results of risk of bias assessment are presented in <a href="#CD010280-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD010280-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD010280-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010280-sec-0060"> <h4 class="title">Allocation</h4> <p>Only one of the included RCTs described an adequate method of generation of randomization sequence and reported an adequate concealment of the sequence of allocation (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). We judged the potential risk for selection bias as unclear. </p> </section> <section id="CD010280-sec-0061"> <h4 class="title">Blinding</h4> <p>The trials conducted by Kiehl et al. and Perkins et al. were open label trials (<a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). We were unable to determine whether the trial conducted by Bolwell et al. used blinding (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>). We judged the potential risk for detection and performance bias as high. </p> </section> <section id="CD010280-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>An ITT analysis was performed in all trials (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The trial by Bolwell et al. had less than 50% of planned sample size accrual (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>). We judged the potential risk for attrition bias as low. </p> </section> <section id="CD010280-sec-0063"> <h4 class="title">Selective reporting</h4> <p>The trial conducted by Perkins et al. reported all major outcomes (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). However, since we did not have access to the trial protocol(s), we could not investigate the potential for selective reporting bias based only on trial publications. We judged the potential risk for selection bias as unclear. </p> </section> <section id="CD010280-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p>A sample size was pre‐planned in two trials (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>), but the planned number was not reached in one trial (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>). Since the trial by Kiehl et al. was published as an abstract, data regarding a priori sample size calculation, and alpha and beta error were not reported (<a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>). We judged the potential risk for other sources bias as low. </p> </section> </section> <section id="CD010280-sec-0065"> <h3 class="title" id="CD010280-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD010280-tbl-0001"><b>Summary of findings for the main comparison</b> Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</a> </p> <p>We included three trials with 174 participants in the analysis. Ninety‐five participants were randomized to the mycophenolate mofetil group and 79 participants to the methotrexate group. The effects of mycophenolate mofetil versus methotrexate are summarized in <a href="./full#CD010280-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD010280-sec-0066"> <h4 class="title">Benefits</h4> <section id="CD010280-sec-0067"> <h5 class="title">Prevention of acute graft‐versus‐host disease grade II to IV</h5> <p>Data on incidence of acute GVHD grade II to IV were extractable from three RCTs (three comparisons, 174 participants) (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis found no statistically significant benefit with use of mycophenolate mofetil versus methotrexate on prevention of grade II to IV acute GVHD (RR 1.25; 95% CI 0.75 to 2.09; P value = 0.39) (<a href="./references#CD010280-fig-0004" title="">Analysis 1.1</a>). Substantial heterogeneity was detected in the analysis (P value = 0.12, I<sup>2</sup> = 52%). </p> </section> <section id="CD010280-sec-0068"> <h5 class="title">Overall survival</h5> <p>Data on overall survival could be extracted from two trials with 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The meta‐analysis found no statistically significant benefit favoring mycophenolate mofetil use (HR 0.73; 95% CI 0.45 to 1.17; P value = 0.19) (<a href="./references#CD010280-fig-0005" title="">Analysis 1.2</a>). No heterogeneity was detected in the analysis (P value = 0.60, I<sup>2</sup> = 0%). </p> </section> <section id="CD010280-sec-0069"> <h5 class="title">Time to neutrophil engraftment</h5> <p>Data on median time to neutrophil engraftment were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis found no significant difference in the median time to neutrophil engraftment between the mycophenolate mofetil group and the methotrexate group (HR 0.77; 95% CI 0.51 to 1.17; P value = 0.23) (<a href="./references#CD010280-fig-0006" title="">Analysis 1.3</a>). Substantial heterogeneity was detected in the analysis (P value = 0.008, I<sup>2</sup> = 86%). </p> </section> <section id="CD010280-sec-0070"> <h5 class="title">Time to platelet engraftment</h5> <p>Data on median time to platelet engraftment were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis found a statistically significant benefit in time to platelet engraftment in the mycophenolate mofetil group compared with the methotrexate group (HR 0.87; 95% CI 0.81 to 0.93; P value &lt; 0.0001) (<a href="./references#CD010280-fig-0007" title="">Analysis 1.4</a>). No heterogeneity was detected in the analysis (P value = 0.43, I<sup>2</sup> = 0%). </p> </section> <section id="CD010280-sec-0071"> <h5 class="title">Incidence of relapse</h5> <p>Data on incidence of relapse were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis found no benefit with use of mycophenolate mofetil versus methotrexate on incidence of relapse (RR 0.84; 95% CI 0.52 to 1.38; P value = 0.50) (<a href="./references#CD010280-fig-0008" title="">Analysis 1.5</a>). No heterogeneity was detected in the analysis (P value = 0.86, I<sup>2</sup> = 0%). </p> </section> <section id="CD010280-sec-0072"> <h5 class="title">Nonrelapse mortality</h5> <p>Data on non‐relapse mortality were extractable from one RCT enrolling 89 participants (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The data from this RCT found no statistically significant benefit with use of mycophenolate mofetil versus methotrexate on nonrelapse mortality (RR 1.21; 95% CI 0.62 to 2.36; P value = 0.57) (<a href="./references#CD010280-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD010280-sec-0073"> <h5 class="title">Prevention of chronic graft‐versus‐host disease</h5> <p>Data on incidence of chronic GVHD were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis found no statistically significant benefit with use of mycophenolate mofetil versus methotrexate on prevention of chronic GVHD (RR 0.92; 95% CI 0.65 to 1.30; P value = 0.62) (<a href="./references#CD010280-fig-0010" title="">Analysis 1.7</a>). No heterogeneity was detected in the analysis (P value = 0.69, I<sup>2</sup> =0%). </p> </section> <section id="CD010280-sec-0074"> <h5 class="title">Quality of life</h5> <p>None of the included studies reported any data related to quality of life.</p> </section> </section> <section id="CD010280-sec-0075"> <h4 class="title">Harms</h4> <section id="CD010280-sec-0076"> <h5 class="title">Incidence of severe mucositis</h5> <p>Data on incidence of severe mucositis were extractable from three RCTs (three comparisons, 174 participants) (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0002" title="FauserA , LinckD S‐EK , BornhauserM , BlauI , KrogerM WH , EhningerG , et al. Mycophenolate mofetil in combination with cyclosporine A (CSA) +/‐ prednisolone versus CsA, methotrexate +/‐ prednisolone for the prophylaxis of acute graft‐versus‐host disease (GvHD) after allogeneic stem cell transplantation: results of a randomized phase. Onkologie2006; Vol. 29, issue Suppl 3:115. [CENTRAL: CN‐00661692] KiehlMG , LinckD , Schaefer‐EckartK , KroegerM , BornhaeuserM , BlauIW . Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation ‐ MMF, a new option in GvHD prophylaxis. Blood2003;11(Pt 1):716a. [CENTRAL: CN‐00484630] KiehlMG , Schafer‐EckartK , KrogerM , BornhauserM , BasaraN , BlauIW , et al. Mycophenolate mofetil for the prophylaxis of acute graft‐versus‐host disease in stem cell transplant recipients. Transplantation Proceedings2002;34(7):2922‐4. [PUBMED: 12431658] KrautL , BunjesD , BornhaeuserM , StockschläderM , EhningerG , FauserA , et al. First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease. Bone Marrow Transplantation2000;Suppl 1:S151. [CENTRAL: CN‐00488428] KrautL , GuenzelmannS , ShipkovaM , Schaefer‐EckartK , KienastJ , BornhaeuserM , et al. Randomized multicenter prospective clinical trial on the efficacy of mycophenolate mofetil in comparison to methotrexate for the prophylaxis of acute GvHD in stem cell transplant recipients. Bone Marrow Transplantation2002;Suppl 2:S177. [CENTRAL: CN‐00488430] ">Kiehl 2002</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis showed a statistically significant benefit with use of mycophenolate mofetil versus methotrexate in reduced incidence of severe mucositis (RR 0.48; 95% CI 0.32 to 0.73; P value = 0.0006) (<a href="./references#CD010280-fig-0011" title="">Analysis 1.8</a>). Low heterogeneity was detected in the analysis (P value = 0.33, I<sup>2</sup> = 10%). </p> </section> <section id="CD010280-sec-0077"> <h5 class="title">Use of total parenteral nutrition</h5> <p>Data on use of total parenteral nutrition were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis showed a statistically significant benefit with use of mycophenolate mofetil versus methotrexate suggesting decreased need of total parenteral nutrition with mycophenolate mofetil use (RR 0.48; 95% CI 0.26 to 0.91; P value = 0.02) (<a href="./references#CD010280-fig-0012" title="">Analysis 1.9</a>). Moderate heterogeneity was detected in the analysis (P value = 0.20, I<sup>2</sup> = 40%). </p> </section> <section id="CD010280-sec-0078"> <h5 class="title">Incidence of narcotic use for pain control</h5> <p>Data on incidence of narcotic use for pain control were extractable from two RCTs enrolling 129 participants (<a href="./references#CD010280-bbs2-0001" title="BolwellB , SobecksR , PohlmanB , AndresenS , RybickiL , KuczkowskiE , et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplantation2004;34(7):621‐5. [PUBMED: 15300236] BolwellBJ , SobecksR , PohlmanB , AndresenS , LichtinA , RybickiL . A prospective, randomized trial comparing cyclosporine + short course methotrexate to cyclosporine + mycophenolate for GVHD prophylaxis in ablative allogeneic BMT. Blood2003;11(Pt 1):711a. [CENTRAL: CN‐00483283] ">Bolwell 2004</a>; <a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The pooled analysis showed a statistically significant benefit with use of mycophenolate mofetil versus methotrexate suggesting a lower narcotic use for pain control with the use of mycophenolate mofetil (RR 0.76; 95% CI 0.63 to 0.91; P value = 0.002) (<a href="./references#CD010280-fig-0013" title="">Analysis 1.10</a>). No heterogeneity was detected in the analysis (P value = 0.53, I<sup>2</sup> = 0%). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010280-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010280-sec-0079"></div> <section id="CD010280-sec-0080"> <h3 class="title" id="CD010280-sec-0080">Summary of main results</h3> <p>The use of mycophenolate mofetil for acute GVHD prophylaxis appears to result in significantly faster platelet engraftment and a lower incidence of severe mucositis compared with methotrexate (<a href="./full#CD010280-tbl-0001">summary of findings Table for the main comparison</a>). As a result, hematopoietic allograft recipients receiving mycophenolate mofetil for acute GVHD prophylaxis are likely to require less total parenteral nutrition or narcotics for pain control compared with people treated with methotrexate. This might translate into lower rates of complications that result from use of total parenteral nutrition or narcotics with the use of mycophenolate mofetil instead of methotrexate and, in turn, could reduce the length of hospital stay. However, we did not detect a statistically significant difference between mycophenolate mofetil and methotrexate in regards to risk of relapse, nonrelapse mortality, or overall survival based. </p> </section> <section id="CD010280-sec-0081"> <h3 class="title" id="CD010280-sec-0081">Overall completeness and applicability of evidence</h3> <p>Despite the fact that a better toxicity profile and faster engraftment are always desirable outcomes after allo‐HCT, the absence of a survival advantage or a favorable effect on prevention of acute or chronic GVHD or a lower transplant‐associated mortality with the use of mycophenolate mofetil limits our ability to recommend mycophenolate mofetil over methotrexate. In addition, we found a statistically significant heterogeneity for the outcome of time to neutrophil engraftment and since there were only two trials reporting this outcome, it was not possible to conduct subgroup or sensitivity analyses to explore the heterogeneity. The findings for this outcome need to be interpreted with caution. In addition, it is important to emphasize that the overall number of relevant trials and included participants is small. Accordingly, it is likely that a greater number of studies would be needed to have sufficient power to detect differences in certain outcomes. A major objective in future research will be to incorporate new trials in this analysis if they become available. We are not aware of any currently ongoing trials comparing mycophenolate mofetil versus methotrexate for the prevention of GVHD in people undergoing allo‐HCT. Nevertheless, there is significant diversity in current investigational approaches for prevention of GVHD. However, in our opinion it is highly unlikely that additional high‐quality trials comparing mycophenolate mofetil and methotrexate will be performed in the near future. </p> </section> <section id="CD010280-sec-0082"> <h3 class="title" id="CD010280-sec-0082">Quality of the evidence</h3> <p>We assessed the quality of the included trials according to the previously described quality domains, and these are represented in <a href="#CD010280-fig-0002">Figure 2</a> and <a href="#CD010280-fig-0003">Figure 3</a>. Overall methodologic quality of included studies was either low or very low. Two included RCTs had a high risk of performance and detection bias. Two included RCTs reported analyses according to the principle of ITT. None of the included RCTs reported data on quality of life and hence we were not able to perform a meta‐analysis on this outcome. Overall, for majority of the outcomes the quality of evidence was low. For the outcome of prevention of acute GVHD grade II to IV the quality of evidence was very low. </p> <div class="figure" id="CD010280-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010280-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD010280-sec-0083"> <h3 class="title" id="CD010280-sec-0083">Potential biases in the review process</h3> <p>We did not find any methodologic issues in the preparation of the review that could put it at risk for bias. We are confident that we have identified all eligible studies. We searched multiple electronic databases and conference proceedings. Once we had compiled the final list of included studies, we consulted content experts to ensure no unpublished studies were missed. We obtained all available data from included studies. We contacted study investigators in an attempt to obtain missing information. Two review authors performed study selection and data extraction. All included studies were RCTs. No subgroup analyses, planned in the protocol (see <a href="#CD010280-sec-0029">Methods</a> section) were conducted due to lack of individual participant data. Due to the small number of included studies, we decided not to perform any sensitivity analyses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010280-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010280-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD010280-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010280-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 1 Prevention of acute GVHD grade II to IV." data-id="CD010280-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 1 Prevention of acute GVHD grade II to IV. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 2 Overall survival." data-id="CD010280-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 2 Overall survival.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 3 Time to neutrophil engraftment." data-id="CD010280-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 3 Time to neutrophil engraftment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 4 Time to platelet engraftment." data-id="CD010280-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 4 Time to platelet engraftment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 5 Incidence of relapse." data-id="CD010280-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 5 Incidence of relapse.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 6 Nonrelapse mortality." data-id="CD010280-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 6 Nonrelapse mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 7 Prevention of chronic GVHD." data-id="CD010280-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 7 Prevention of chronic GVHD. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 8 Incidence of severe mucositis." data-id="CD010280-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 8 Incidence of severe mucositis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 9 Use of total parenteral nutrition." data-id="CD010280-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 9 Use of total parenteral nutrition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010280-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/urn:x-wiley:14651858:media:CD010280:CD010280-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_t/tCD010280-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 10 Incidence of narcotic use for pain control." data-id="CD010280-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Mycophenolate mofetil versus methotrexate, Outcome 10 Incidence of narcotic use for pain control. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/media/CDSR/CD010280/image_n/nCD010280-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010280-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people receiving allogeneic hematopoietic stem cell transplantation<br/> <b>Settings:</b> inpatients/hospital<br/> <b>Intervention:</b> mycophenolate mofetil versus methotrexate </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Methotrexate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Mycophenolate mofetil </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Overall survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HR 0.73</b> </p> <p>(0.45 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Prevention of acute GVHD grade II to IV</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.25</b> <br/> (0.75 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>174<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>595 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>744 per 1000</b> <br/> (446 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>368 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>460 per 1000</b> <br/> (276 to 769) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of relapse</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.84</b> <br/> (0.52 to 1.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>348 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>293 per 1000</b> <br/> (181 to 481) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>386 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>324 per 1000</b> <br/> (201 to 533) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Nonrelapse mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.21</b> <br/> (0.62 to 2.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>89<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (158 to 603) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (158 to 602) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Prevention of chronic GVHD</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.92</b> <br/> (0.65 to 1.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>460 per 1000</b> <br/> (325 to 650) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>539 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>496 per 1000</b> <br/> (350 to 701) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of severe mucositis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.48</b> <br/> (0.32 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>174<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>557 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>267 per 1000</b> <br/> (178 to 407) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>278 per 1000</b> <br/> (185 to 423) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Use of total parenteral nutrition</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.48</b> <br/> (0.26 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>606 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>291 per 1000</b> <br/> (158 to 552) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>614 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>295 per 1000</b> <br/> (160 to 559) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Incidence of narcotic use for pain control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.76</b> <br/> (0.63 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>909 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>691 per 1000</b> <br/> (573 to 827) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>5</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>921 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>700 per 1000</b> <br/> (580 to 838) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>GVHD:</b> graft‐versus‐host disease; <b>HR:</b> hazard ratio; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Only one of the included articles described an adequate method of generation of randomization sequence and reported an adequate concealment of the sequence of allocation (<a href="./references#CD010280-bbs2-0003" title="PerkinsJ , FieldT , KimJ , Kharfan‐DabajaMA , FernandezH , AyalaE , et al. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft‐versus‐host disease prophylaxis. Biology of Blood and Marrow Transplantation2010;16(7):937‐47. [PUBMED: 20102746] ">Perkins 2010</a>). The trials conducted by Kiehl et al. and Perkins et al. were open‐label trials.<br/> <sup>2</sup> The pooled estimate has wide confidence intervals, which reflects lower precision of the estimate.<br/> <sup>3</sup> Only three RCTs are published comparing mycophenolate mofetil versus methotrexate which reflects potential publication bias.<br/> <sup>4</sup> Data were reported in only one RCT. </p> <p><sup>5</sup> Generated by GRADEpro software based on event rate in the control arm of included studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic hematopoietic stem cell transplantation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/full#CD010280-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010280-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mycophenolate mofetil versus methotrexate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Prevention of acute GVHD grade II to IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.75, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.45, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Time to neutrophil engraftment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.51, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Time to platelet engraftment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.81, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incidence of relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.52, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nonrelapse mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.62, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Prevention of chronic GVHD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.65, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Incidence of severe mucositis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.32, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Use of total parenteral nutrition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.26, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Incidence of narcotic use for pain control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.63, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mycophenolate mofetil versus methotrexate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010280.pub2/references#CD010280-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010280.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010280-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010280-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010280-note-0001">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010280\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010280\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010280\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010280\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010280\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010280.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010280.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010280.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010280.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010280.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720186735"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010280.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720186738"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010280.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dfb063e8e9377',t:'MTc0MDcyMDE4Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 